The role of reduced glutathione (GSH) on ascorbate-and dopamine-induced apoptosis in PC12 cells was investigated. Ascorbate is a potent reducing agent and is thus expected to protect against dopamine-induced apoptosis. However, we found that both ascorbate and dopamine killed PC12 cells and ascorbate enhanced dopamine-induced toxicity. The EC 50 of cell toxicity induced by ascorbate, dopamine and dopamine plus 0.1 mM ascorbate during 24-h treatment were 0.93±0.15 mM, 0.18±0.05 mM and 0.13±0.04 mM, respectively. When the medium contained 10 mM GSH, the EC 50 increased approximately three-and sevenfold for ascorbate and dopamine, respectively. With increased treatment duration, no further toxic effects of ascorbate or dopamine were observed. The GSH synthesis inhibitor, DLbuthionine-(S,R)-sulfoximine (BSO), induced cell toxicity and potentiated the toxic effects of ascorbate and dopamine, suggesting that endogenous GSH participates in protecting against basal oxidative stress. We conclude that both ascorbate and dopamine induce apoptosis in PC12 cells and further that GSH protects them from apoptosis. This study indicates that the toxic effects of ascorbate are potentially due to an oxidative mechanism, similar to that induced by dopamine.
Introduction
Parkinson's disease is characterized by the degeneration of central dopaminergic neurons that undergo programmed cell death (PCD, also called apoptosis). The cause of neural loss is unclear, but there is increasing evidence that oxidizing agents, free radicals, loss of the antioxidant glutathione (GSH), increased iron levels and mitochondrial complex I deficiencies may play significant roles (Jenner et al. 1992; Owen et al. 1996) . Under normal conditions, cells possess defense mechanisms that include catalytic enzyme systems (e.g. superoxide dismutase, glutathione peroxidase and catalase) and radical scavengers (e.g. vitamin E, ascorbate and GSH). Dopamine (DA), the endogenous neurotransmitter of nigrostriatal neurons, is an established apoptotic agent on dopaminergic neurons (Graham et al. 1978; Gabbay et al. 1996) . DA oxidation produces tissue damage similar to that seen in Parkinson's disease (Hastings et al. 1996) . PC12 cells, originated from rat pheochromocytoma cells (Greene and Tischler 1976) , secrete DA (Greene and Rein 1978) , produce GSH and express DA receptors (Sampath et al. 1994 ). PC12 cells share many common characteristics with substantia nigra cells and therefore have been widely used as a model system for the study of DA-producing substantia nigra neurons (Snyder et al. 1986) .
Ascorbate (AA) is a well-known reducing agent and is involved in several types of protective mechanisms. Brain contains much higher concentration of AA (1-2 mM) than peripheral blood (0.02-0.08 mM ; Hornig 1975; Schenk et al. 1982) suggesting that AA plays an important physiological role in the CNS. However, we observed that the physiological concentration of AA (1 mM) is toxic to PC12 cells and a subthreshold concentration of AA (0.1 mM) potentiates DA-induced toxic effects via apoptotic mechanisms (F. Si, G.M. Ross, S.H. Shin, unpublished work) .
GSH is a major scavenging compound of oxidative chemicals. GSH levels are decreased selectively in the substantia nigra in Parkinson's disease and not in other brain areas or in other neurodegenerative diseases (Jenner et al. 1992) . The changes in GSH levels in the brain thus appear to be an early marker of Parkinson's disease (Jenner et al. 1992) . Several studies using cultured cells also demonstrate that GSH is involved in protecting dopaminergic neurons from the neurotoxic effects of 6-hydroxydopamine (6-OHDA) and MPTP (Spina et al. 1992) , PC12 cells from 6-OHDA and DA-induced apoptosis (Walkinshaw and Waters 1994) and human neuronal cells from DA-induced apoptosis (Gabbay et al. 1996) . We tested the effect of GSH on AA-and DA-induced apoptosis in PC12 cells and found that it protected against the toxic effects of both agents.
DL-Buthionine-(S,R)-sulfoximine (BSO), an irreversible inhibitor of γ-glutamylcysteine synthetase, decreases GSH levels in rat brain (Owen et al. 1996) and in cultured cells (Gabbay et al. 1996) . The toxicity of 6-OHDA and DA is potentiated when endogenous GSH is depleted by BSO (Pileblad et al. 1989; Gabbay et al. 1996) . In the present study we demonstrated that BSO induced toxic effects in PC12 cells and potentiated the AA-and DA-induced apoptosis.
Materials and methods

Materials
AA, DA, GSH, BSO, p-nitrophenyl phosphate (Sigma 104 phosphatase substrate) and Trypan blue were purchased from Sigma Chemicals; Dulbecco's modified Eagles' medium (DMEM) was purchased from Gibco; sodium acetate was purchased from J. T. Baker Chemicals; Phillipsbur and Triton X-100 were purchased from BDH Chemicals.
Cell cultures and treatments PC12 cells were obtained from American Type Culture Collection (ATCC) and grown in DMEM containing 12.5% horse serum and 5% fetal calf serum in tissue culture flasks. The flasks were placed in a water-jacketed incubator at 37°C under a water saturated atmosphere of 5% CO 2 and 95% air. Cells were maintained in culture medium until they were confluent, after which they were incubated in a calcium-magnesium free Gey's balanced salt solution (pH 7.4; NaCl 8.6 g/l, KCl 0.37 g/l, Na 2 HPO 4 ·2H 2 O 0.15 g/l, KH 2 PO 4 0.03 g/l, NaHCO 3 0.227 g/l, Glucose 1 g/l) at 37°C for 30 min to harvest them. The suspended cells were pelleted by centrifugation (500×g for 3 min) and the pellet was resuspended in culture medium. At a concentration of 3-4×10 4 cells/ml, a 100 µl aliquot of cell suspension was distributed to each well of Microtest tissue culture plates (96-well, flat bottom). The doubling time of PC12 cells in our experimental condition was about 36 h. After 36 h, the monolayered cells were treated with pharmacological agents by replacing fresh culture medium containing AA (1 µM-1 mM) and DA (1 µM-1 mM ) with or without 0.1 mM AA and incubated for 1-72 h as controls. The effect of GSH on DA and AA was tested by treating the cells the same way as controls except the medium contained 10 mM GSH. The effect of GSH (2.5-20 mM) alone on PC12 cells was tested by incubating cells for 24 h. The pH of all AA and GSH solutions was adjusted to 7.4 with 1 M NaOH. For investigating the effect of BSO, cells were treated with 1.5-6 mM of BSO with or without 1 mM of AA or DA for 24 h. In another experiment, the cells were treated with 0.01-1 mM DA with or without 3 mM BSO for 6 h. Cell numbers were evaluated by assaying acid phosphatase activity (Connolly et al. 1986; Ueda et al. 1994 ).
Acid phosphatase assay
At the end of treatment with the pharmacological agents, the medium was removed gently and the cells were washed once with 200 µl of phosphate-buffered saline (PBS; NaCl 0.15 M, Na 2 HPO 4 0.01 M; pH 7.6), then 100 µl aliquot of buffer containing 0.1 M sodium acetate (pH 5.5), 0.1% (vol/vol) Triton X-100 and 10 mM p-nitrophenyl phosphate were added to each well. The plates were placed in a water-jacketed incubator at 37°C for 2 h. The reaction was stopped by the addition of 10 µl 1 M NaOH to each well and the optical densities (ODs) were measured at 405 nm using a microplate reader (MCC/340; Titertek Multiskan, Finland).
In order to establish the relationship between acid phosphatase activities and the number of living cells, a wide range of PC12 cells (100-20 000 cells) were seeded in each well for 36 h. A direct linear relationship between the number of cells and ODs was shown in the range of 200-8000 cells per well (inset, Fig. 1 ; correlation coefficient r=0.989). When more than 8000 cells were in one well, the relationship became nonlinear ( Fig. 1) indicating that the high OD values distorted the cell numbers. Therefore, 3000-4000 cells per well were seeded in all subsequent experiments.
Trypan blue exclusion test was performed for determining that the changes in acid phosphatase activity after treatment indicated changes in cell numbers. Cells were grown and treated exactly the same as that in the previous experiments. The cells were treated with 1 mM DA or 1 mM AA. After 24 h, the old medium was removed and the wells were washed in 200 µl PBS. Then 0.4% Trypan blue solution was added to the wells and incubated for 10 min. Then the solution was removed and the cells in the wells were counted directly under a microscope. There were 5% live cells left in the wells after DA treatment and about 60% live cells in the AA treatment group relative to controls. These observations were consistent with the results measured by acid phosphatase assay, confirming that the changes in acid phosphatase activities indicated changes in cell numbers (see Results).
Statistic analysis
Differences between groups were evaluated by t-test in GraphPad Prism 2.0. A difference of P<0.05 was considered to be statistically significant. Data were expressed as the means±SEM of the indicated number of replicates performed.
Results
Protective effect of GSH on DAand AA-induced apoptosis in PC12 cells PC12 cells were treated with different concentrations of AA, DA and DA plus 0.1 mM AA with or without GSH Fig. 1 The relationship of PC12 cell number and acid phosphatase activities. Different numbers of PC12 cells (100-200 000 per well) were loaded in 96-well plates and incubated for 36 h. The cells were then assayed for acid phosphatase activities. The colour development was determined using a microplate reader at 405 nm. Each point shows the mean±SEM of 12 replicates during a period of 1-72 h. One-hour treatments with AA, DA and DA plus AA did not change acid phosphatase activities (data not shown) in any of the three groups. After a 3-h treatment period, the highest concentration (1 mM) of AA, DA or DA plus 0.1 mM AA significantly depressed acid phosphatase activities to 87±3% (P<0.05), 74±4% (P<0.01) and 74±3% (P<0.01), respectively (Fig.  2a) . GSH itself up to 20 mM had no effect on acid phosphatase activity in PC12 cells (Fig. 3) . When 10 mM GSH was introduced in the culture medium, the toxic effect of AA and DA was completely blocked during a 3-h period in all three groups (Fig. 2a) .
After 24-h treatments, AA-treated groups (up to 0.1 mM) did not exhibit altered viability, but 1 mM AA depressed the phosphatase activities to 48±2% (P<0.001) while 71±7% (P<0.001) in the presence of 10 mM GSH Fig. 3 The effect of GSH on PC12 cells. PC12 cells were treated with 2.5-20 mM GSH for 24 h and then acid phosphatase activities were assayed. Each point represents mean±SEM of 16 replicates Fig. 2b ). In DA-treated groups, 0.01, 0.1 and 1 mM DA significantly inhibited the phosphatase activities to 89±5% (P<0.05), 74±3% (P<0.01) and 5±0.7% (P<0.001), respectively (middle panel, Fig. 2b ). GSH completely prevented the toxicity of 0.01-0.1 mM DA but partially (48%) prevented the decrease in acid phosphatase activity induced by 1 mM DA. Even though 0.1 mM AA itself did not change the phosphatase activity, when it was added to DA-treated groups, 0.01, 0.1 and 1 mM DA inhibited the phosphatase activities to 85±6% (P<0.05), 61±6% (P<0.01) and 5±1.4% (P<0.001), respectively (lower panel, Fig. 2b ). When DA plus AA-treated and DAtreated groups were compared, the phosphatase activities of the former group were significantly lower at 0.1 mM DA, indicating the potentiating effect of AA on DA-induced toxicity. The protective effect of GSH on DA plus 0.1 mM AA was the same as that of DA treatment alone. Namely, GSH completely blocked the toxic effect of AA plus low concentrations of DA (up to 0.1 mM) and partially prevented the cell toxicity induced by AA plus 1 mM DA.
The concentration of AA, DA or DA plus 0.1 mM AA inducing half maximal toxic effect (EC 50 ) during a 24-h treatment was 0.93±0.15 mM, 0.18±0.05 mM and 0.13±0.04 mM, respectively. In the presence of GSH, the EC 50 for the three groups significantly increased to 2.40±1.56 mM, 1.19±0.39 mM and 1.07±0.34 mM, suggesting that the efficiencies of AA and DA on apoptosis were reduced by GSH approximately three-and sevenfold, respectively (Table 1) .
When incubation periods were extended to 48 h (Fig.  2c ) or up to 72 h (data not shown), general trends of the inhibitory actions on acid phosphatase activities induced by AA, DA or DA plus AA were similar to that of the 24-h-treated groups. The protective effect of GSH exhibited the same extent on AA as that of 24-h treatment but only slightly at 0.1 mM DA and no effect on 1 mM DA (Fig. 2c) .
Effect of BSO on AA-and DA-induced apoptosis in PC12 cells PC12 cells were treated with BSO with or without 1 mM AA or DA for 24 h. BSO at concentrations of 1.5, 3 and 6 mM decreased the acid phosphates activities to 78±2% (P<0.01), 68±8% (P<0.01) and 57±5% (P<0.001), respectively (Fig. 4) , indicating that BSO itself killed PC12 cells in a dose-dependent manner. By 24-h incubation, 1 mM AA significantly inhibited acid phosphatase activity to 74% and the acid phosphatase activities inhibited by BSO plus AA were significantly lower than both BSOand AA-treated alone, suggesting that BSO and AA had a synergistic toxic effect on PC12 cells (upper panel, Fig. 4) . However, during 24-h treatment with DA, the effect of BSO on DA could not be observed, since 1 mM 266 DA alone had already reached the maximal toxic effect on the cells (lower panel, Fig. 4) . When PC12 cells were treated with 0.01-1 mM DA with or without 3 mM BSO for 6 h, BSO did not change the acid phosphatase activity but potentiated the toxicity of DA in all dose ranges (Fig. 5 ).
Discussion
The major mechanisms of DA-induced apoptosis are oxidative stress and covalent binding of DA's oxidative products to vital proteins (Graham et al. 1978; Ross et al. 1993 Ross et al. , 1995 . Monoamine oxidase inactivates DA by oxidative deamination, which produces 3,4-dihydroxyphenylacetaldehyde (DOPAL). The DOPAL is taken up by the DA uptake system and selectively accumulates in and damages cells of the substantia nigra (Mattammal et al. 1995) . The DOPAL is further oxidized to 3,4-dihydroxyphenyl acetic acid (DOPAC). During the oxidative deamination processes, other cytotoxic products are also generated, such as hydrogen peroxide and superoxide radicals (Olanow 1990 ). Our observations that the reducing agent GSH inhibits DA toxicity support that DA induces apoptosis through an oxidative stress mechanism. AA has many different biological actions. AA potentiates DA's inhibitory action on prolactin release (Shin et al. 1990) . AA is an important reducing agent and thus defends against singlet oxygen, superoxide anions, free hydroxy radicals (Bielski et al. 1975; Nishikimi 1975; Bodaness and Chan 1979) and inhibits catechol oxidation (Shin et al. 1990) . As a general free radical scavenger, AA suppresses DA-or ferrous iron-induced apoptosis in PC12 cells (Velez-Pardo et al. 1997) . However, we found that a physiological concentration of AA (1 mM) caused apoptosis in PC12 cells and a subthreshold concentration of AA (0.1 mM) potentiated DA's apoptotic action. These observations are consistent with previous work that AA acts as a pro-oxidant for the induction of apoptosis in human promyelocytic leukemic HL-60 cells (Sakagami and Satoh 1997) and 0.5-2 mM AA potentiates DA-induced apoptosis in a human neuronal cell line (Gabbay et al. 1996) . Offen et al. (1996) also demonstrate that AA cannot rescue PC12 cells from DA-induced apoptosis.
A biphasic effect of AA, anti-oxidant or pro-oxidant, has been shown by Wefers and Sies (1988) , and AA depends on vitamin E in switching the role of a potentially damaging agent to a protective agent. AA exhibits an additional anti-lipoperoxidant effect against oxidized lipoproteins on lymphoid cell lines when AA is used together with vitamin E and rutin (Negre-Salvayre et al. 1991) .
In vitamin E deficiency the pro-oxidant effect of AA is abolished when GSH is present (Wefers and Sies 1988) . Taken together, the balance between anti-and pro-oxidant effect of AA is dependent on vitamin E, GSH or other reducing agents.
While the molecular details of the effects of AA on apoptosis are still not established, we propose that AA toxicity is due to a serial redox reaction. It is known that AA is oxidized to dehydroascorbic acid (DHA) and rapidly ferried into cells by glucose transporters in the form of DHA, and then the accumulated DHA is reduced back to AA in cytosol by the action of DHA reductase (Vera et al. 1995) . The reduction of DHA to AA means that other cytosolic component(s) should be oxidized, since oxidation-reduction reactions transfer electron from one compound to another. This oxidation may be a potential cause of cell death. In essence, GSH, a major antioxidant in the cellular defense system, can inhibit the oxidation reaction from AA to DHA or from the oxidation of some cytosolic components thus prevent AA-induced apoptosis. This proposed mechanism is supported by our observations that GSH inhibited AA-induced oxidation.
DA toxicity was enhanced in the presence of AA (Fig. 2) . The potentiation effect of AA may be due to an enhanced oxidation during the conversion processes from DHA to AA in cytosol, and/or more DA is available due to increased DA half-life in presence of AA. The half-life of DA in DMEM is 36 min and it is extended to 792 min in the presence of 0.1 mM AA (Shin et al. 1990 ). However, the second possibility is excluded because GSH, which increases the half-life of DA, decreased apoptotic action of DA and AA (Fig. 2) . Therefore, DA is probably exposed to more oxidation stress caused by DHA than an increase in stored DA in granules during uptake processes.
Both AA and DA reached their maximal toxic effect at around 24 h and no further toxic effect was observed when the incubation period was prolonged to 48 h (Fig.  2) , suggesting that the pharmacological agents are no longer active after 24 h. GSH had the same protective effect on AA during a 24-h or 48-h treatment period, while much less effect on DA when the cells were incubated for 48 h.
DA decreases intracellular GSH levels in human neuronal cells (Gabbay et al. 1996) , and the intracellular GSH levels fall concomitant with the onset of apoptosis (van den Dobbelsteen et al. 1996) . BSO, an inhibitor of GSH formation, potentiated the neurotoxic effect of DA and AA in PC12 cells in our experiments, suggesting that endogenous GSH participates in protecting against DA and AA neurotoxicity. These observations confirm that PC12 cells synthesize GSH (Sampath et al. 1994) and support our proposed mechanism that AA causes oxidative apoptosis. We also observed that BSO itself killed PC12 cells in a dose-and time-dependent manner. However, Owen and coworkers (1996) demonstrate that the loss of GSH caused by BSO is not sufficient to produce degeneration of the nigrostriatal pathway in rat brain. Gabbay et al. (1996) reports that 1-6 mM of BSO has no effect on human neuronal cells during 24-h treatment. Our studies suggest that PC12 cells are more vulnerable to BSO than human neuronal cells and rat brain cells. We will investigate the intracellular GSH levels in PC12 cells in future studies.
Some mammalian species, such as humans, monkeys and guinea pigs, have lost their ability to synthesize AA (Chaterjee et al. 1961) . AA production is accompanied by GSH consumption in the liver with transfer of GSH to oxidized glutathione (GSSG; Banhegyi et al. 1996) . Our observations that AA kills PC12 cells and potentiates DA's toxic effects may be one of the reasons why the loss of AA-synthesizing ability can be advantageous. The levels of AA in Parkinson's disease are unchanged (Riederer et al. 1989) . AA is an anti-oxidant or pro-oxidant in different situations and therefore the role of AA in Parkinson's disease needs further investigation.
